Table 2 Radiotherapy
From: Impact of HIV infection on consolidative radiotherapy for non-Hodgkin diffuse large B-cell lymphoma
Radiotherapy treatment | HIV | p | |
|---|---|---|---|
No N = 331 (92.2%) | Yes N = 28 (7.8%) | ||
Dose | |||
Lower than 30Gy | 29 (8.8%) | 4 (14.3%) | 0.779 |
30 or 30.6Gy | 140 (42.3%) | 11 (39.3%) | |
36Gy | 143 (43.2%) | 11 (39.3%) | |
Higher than 36Gy | 19 (5.7%) | 2 (7.1%) | |
RT fractionation | |||
180 cGy/fraction | 173 (52.3%) | 15 (52.4%) | 0.633 |
200 cGy/fraction | 127 (38.4%) | 9 (32.1%) | |
Others | 31 (9.4%) | 4 (14.3%) | |
RT technique | |||
EBRT | 8 (2.4%) | 0 | 0.180 |
IFRT | 81 (24.5%) | 3 (10.7%) | |
ISRT | 91 (27.5%) | 12 (42.9%) | |
Only bulky/ PR | 151 (45.6%) | 13 (46.4%) | |
Radiotherapy toxicities | |||
Greatest toxicity grade | |||
No toxicity | 72 (21.8%) | 5 (17.9%) | 0.567 |
Grade I | 128 (38.7%) | 13 (46.4%) | |
Grade II | 114 (34.4%) | 10 (35.7%) | |
Grade III | 17 (5.1%) | 0 | |
Grade IV | 0 | 0 | |
Fatigue | |||
No | 256 (77.3%) | 11 (39.3%) | < 0.005 |
Yes | 75 (22.7%) | 17 (60.7%) | |
Hematologic | |||
No | 320 (96.7%) | 24 (85.7%) | 0.022 |
Yes | 11 (3.3%) | 4 (14.3%) | |
Endocrinologic | |||
No | 324 (97.9%) | 28 (100%) | 0.564 |
Yes | 7 (2.1%) | 0 | |
Metabolic | |||
No | 328 (99.1%) | 28 (100%) | 0.783 |
Yes | 3 (0.9%) | 0 | |
Gastrointestinal | |||
No | 339 (72.2%) | 22 (78.6%) | 0.315 |
Yes | 92 (27.8%) | 6 (21.4%) | |
Infections | |||
No | 313 (94.6%) | 26 (92.9%) | 0.474 |
Yes | 18 (5.4%) | 2 (7.1%) | |
Lymphedema | |||
No | 322 (97.3%) | 28 (100%) | 0.477 |
Yes | 9 (2.7%) | 0 | |
Musculoskeletal | |||
No | 322 (97.3%) | 28 (100%) | 0.477 |
Yes | 9 (2.7%) | 0 | |
Neurological | |||
No | 324 (97.9%) | 27 (96.4%) | 0.481 |
Yes | 7 (2.1%) | 1 (3.6%) | |
Pain | |||
No | 255 (77.0%) | 23 (82.1%) | 0.363 |
Yes | 79 (23.0%) | 5 (17.9%) | |
Lung | |||
No | 307 (92.7%) | 28 (100%) | 0.133 |
Yes | 24 (7.3%) | 0 | |
Genitourinay | |||
No | 326 (98.5%) | 27 (96.4%) | 0.388 |
Yes | 5 (1.5%) | 1 (3.6%) | |
Vascular | |||
No | 326 (98.5%) | 28 (100%) | 0.665 |
Yes | 5 (1.5%) | 0 | |